Navigation Links
Colorado-Based Spectranetics Corporation to Pay $5 Million to Resolve Allegations Relating to its Medical Devices
Date:12/29/2009

WASHINGTON, Dec. 29 /PRNewswire-USNewswire/ -- Spectranetics Corporation, a medical device manufacturer, has agreed to pay the United States $4.9 million in civil damages plus a $100,000 forfeiture to resolve claims against the company, the Justice Department announced today. The claims arise from allegations that the company illegally imported unapproved medical devices and provided them to physicians for use in patients, conducted a clinical study in a manner that failed to comply with federal regulations and promoted certain products for procedures for which the company had not received Food and Drug Administration approval or clearance.

The company manufactures, distributes and sells certain medical lasers and peripheral devices for those lasers, such as lead wires that guide the lasers through vascular tissue and catheters that carry and contain the lasers inside the veins, including, specifically, the CVX-300 Medical Laser and the CliRpath Turbo Laser Catheter, the TURBO Elite Laser Ablation Catheter, and the TURBO-Booster Laser Guide Catheter.

In resolving this matter, Spectranetics has entered into a civil settlement agreement and a non-prosecution agreement with the United States. The company also entered into a corporate integrity agreement with the Office of Inspector General of the Department of Health and Human Services.

According to the non-prosecution agreement, officers and employees who acted on behalf of the company engaged in multiple areas of wrongdoing. Specifically, Spectranetics illegally imported unapproved medical devices from overseas manufacturers and distributed those devices for use in human patients, and failed to meet its reporting obligations to FDA regarding a study named "CORAL" (COronary graft Results after Atherectomy with Lasers) and another associated study in connection with the devices listed above.

Under the terms of the non-prosecution a
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Spectranetics Enrolls First Patient in PATENT Trial for the Treatment of Instent Restenosis
2. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
3. CEL-SCI Corporation Releases Letter to Shareholders
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
7. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
8. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
9. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
11. Immunosyn Corporation Releases SF-1019 Study Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013 /PRNewswire-iReach/ -- Today at American Society for ... Ginocchio discussed Specific Technologies blood culture ... of microorganisms producing bloodstream infection. Dr. Ginocchio is ... Division of Infectious Disease Diagnostics at North Shore-LIJ ... health system. (Photo: http://photos.prnewswire.com/prnh/20130520/CG16829 ) ...
(Date:5/20/2013)... Calif. , May 20, 2013 /PRNewswire-iReach/ -- ... of the first study demonstrating detection of pathogenic ... Yersinia pestis and Bacillus anthracis ... and Prevention,s list of potential bio-threats. This seminal ... and Technology Laboratory, Salisbury ...
(Date:5/20/2013)... , May 20, 2013  Hill-Rom Holdings, Inc. (NYSE: ... a management presentation at the 38 th Annual ... on May 30, 2013, at 1:30 p.m. ... You are invited to listen to the live ... or access it directly at http://www.media-server.com/m/p/f7bj3q84 . A ...
Breaking Medicine Technology:Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2
... 7, 2011 Rochester Medical Corporation (NASDAQ: ... the previously announced purchase of Laprolan B.V., the former ... BioSciences N.V. Under the terms of the purchase agreement ...  For more information regarding this transaction please refer to ...
... April 7, 2011 Ascension Orthopedics, Inc., a world ... the TITAN Modular Total Shoulder.  The surgeries were performed ... Baltimore, MD.     "I have been ... of years in my practice. Now that Ascension has ...
Cached Medicine Technology:Ascension Orthopedics Announces TITAN™ Modular Shoulder Implantations at Union Memorial Hospital 2
(Date:5/20/2013)... DC (PRWEB) May 20, 2013 Medicare ... are overwhelmingly satisfied, citing lower costs, convenient access to ... from Hart Research Associates released today by the Pharmaceutical ... D seniors (9.5 million) are currently enrolled in plans ... pharmacy choices, and overall value of plans with preferred ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 A new ... by MedEx Direct, the creators of the MedEx Pack ... the Benefits of Pharmacy Home Delivery, in order to provide ... their prescriptions are handled. Clyde Furuta, MedEx Direct owner ... home delivery is that with a product like the MedEx ...
(Date:5/20/2013)... improved health care and significant reductions in drug costs ... between physicians and drug company representatives who promote the ... This system, which has been in place for decades, ... to date on new medications, and always provided generous ... the newest drugs, as well as other supplies and ...
(Date:5/20/2013)... T.E.N. announced today that it would ... Security Executive® Northeast Awards now through Friday, July ... Security Executive® of the Year and ISE® People’s ... a positive impact on their organizations through risk ... security; and the ISE® Project of the Year, ...
(Date:5/20/2013)... Geneva, Switzerland (PRWEB) May 20, 2013 ... discovery for lead identification and cell line development for ... that the Company’s co-founder will present data on the ... Development & Engineering Conference, May 20 - 23 ... La Jolla, California. Selexis’ co-founder and scientific advisory board ...
Breaking Medicine News(10 mins):Health News:Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2Health News:Benefits of Pharmacy Home Delivery Report Published by MedEx Direct 2Health News:Breakup of physician, drug company relationship could improve health care, cut cost 2Health News:Breakup of physician, drug company relationship could improve health care, cut cost 3Health News:T.E.N. Announces Call for Nominations for the ISE® Northeast Awards 2013 2Health News:T.E.N. Announces Call for Nominations for the ISE® Northeast Awards 2013 3Health News:Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering 2Health News:Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering 3
... Children, WASHINGTON, Oct. 3 Campaign for ... veto of the,Children,s Health Insurance Program Reauthorization bill ... nation,s broken health care systems. The bill,the president ... for 6.6 million children and provide coverage to ...
... Information,Systems, Inc., (Nasdaq: MEDW ) announced that ... the company regarding the company,s,non-compliance with Nadsaq Marketplace ... company,s audit committee. This issue arose,due to the ... an audit,committee member. On October 2, 2007, ...
... say , WEDNESDAY, Oct. 3 (HealthDay News) -- Identifying ... the best chemotherapy for patients, U.S. research suggests. , ... most likely to respond to standard first-line therapy and ... a second-line therapy, based on gene expression profiling," lead ...
... outcomes for high-risk patients , , WEDNESDAY, Oct. 3 (HealthDay ... the bare-metal kind for high-risk patients with blocked coronary ... of restenosis -- having the artery become blocked again ... following two years for those getting drug-coated stents, 7.4 ...
... Oct. 3 Abaxis, Inc.,(Nasdaq: ABAX ), ... systems, announced today the launch of the Kidney,Check ... Piccolo xpress(TM) point of,care analyzer. The new ... and,radiology centers in the United States to determine ...
... Nowhere are the,consequences of premature birth more evident than ... the next week, 563 babies,will be born too soon ... watch their babies be admitted into a NICU. Having ... the most frightening and overwhelming,experiences a parent faces. ...
Cached Medicine News:Health News:Mediware Information Systems, Inc. Receives Notice from the Nasdaq Stock Market 2Health News:Gene Tests Match Up Lung Tumors, Best Treatment 2Health News:Study Finds Benefits With Drug-Coated Stents 2Health News:Study Finds Benefits With Drug-Coated Stents 3Health News:Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers 2Health News:Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers 3Health News:March of Dimes NICU Family Support(R) Programs Give Florida Families Comfort and Information During a Crisis 2
... The innovative E.coli ... Pro-Lab offers definitive identification ... the use of a ... the possibility of cross-reactions ...
A single tube that performs two rapid tests for E. coli from culture. ColiScreen™ combines both the indole test with the glucuronidase test to increase the specificity....
The Oxoid Legionella Latex Test is a latex agglutination test for the identification of predominant Legionella species grown on plate media from patients with suspected Legionellosis or from environm...
Inquire...
Medicine Products: